August 2, 2010

India's Hester Bioscience reports increased turnover in Q1

Hester has reported a turnover of Rs104.98 million (US$2.27 million) in Q1 ended June 30, 2010, as compared to Rs92.05 million (US$1.99 million) for the previous corresponding period.

NP for Q1 is recorded at Rs18.28 million (US$395,673) against Rs17.94 million (US$388,313) for the previous corresponding period.
 

Cash Profits (NP + Depreciation) is recorded at Rs28.55 million (US$618,233) as compared to Rs26.99 million (US$584,452) for the previous corresponding period.

 
EPS has been registered at Rs3.52 (US$0.076) as on June 30, 2010 as against Rs3.46 (US$0.074) in the same period last year.

Known for its range of poultry vaccines, the company entered the large animal vaccine space by producing vaccines for cattle, sheep and dogs by the second quarter of 2008.

Previously, the company's vaccine production capacity has risen from 1.2 billion doses to 5 billion at its Kadi plant. Three to four types of vaccines will be introduced for large animals.